KR102669683B1 - 장세척을 위한 경구용 고형제제 - Google Patents
장세척을 위한 경구용 고형제제 Download PDFInfo
- Publication number
- KR102669683B1 KR102669683B1 KR1020210193139A KR20210193139A KR102669683B1 KR 102669683 B1 KR102669683 B1 KR 102669683B1 KR 1020210193139 A KR1020210193139 A KR 1020210193139A KR 20210193139 A KR20210193139 A KR 20210193139A KR 102669683 B1 KR102669683 B1 KR 102669683B1
- Authority
- KR
- South Korea
- Prior art keywords
- less
- sulfate
- dosage form
- present
- solid dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230035478A KR20230043086A (ko) | 2020-12-31 | 2023-03-17 | 장세척을 위한 경구용 고형제제 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200189689 | 2020-12-31 | ||
| KR20200189688 | 2020-12-31 | ||
| KR1020200189689 | 2020-12-31 | ||
| KR1020200189688 | 2020-12-31 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230035478A Division KR20230043086A (ko) | 2020-12-31 | 2023-03-17 | 장세척을 위한 경구용 고형제제 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20220097340A KR20220097340A (ko) | 2022-07-07 |
| KR102669683B1 true KR102669683B1 (ko) | 2024-05-28 |
Family
ID=82259801
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210193139A Active KR102669683B1 (ko) | 2020-12-31 | 2021-12-30 | 장세척을 위한 경구용 고형제제 |
| KR1020230035478A Pending KR20230043086A (ko) | 2020-12-31 | 2023-03-17 | 장세척을 위한 경구용 고형제제 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230035478A Pending KR20230043086A (ko) | 2020-12-31 | 2023-03-17 | 장세척을 위한 경구용 고형제제 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240075060A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4272734A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024501839A (cg-RX-API-DMAC7.html) |
| KR (2) | KR102669683B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3202758A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022146089A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102635438B1 (ko) * | 2022-10-07 | 2024-02-13 | 주식회사태준제약 | 장 세척을 위한 고형제제 및 이의 제조방법 |
| TW202508608A (zh) * | 2023-05-12 | 2025-03-01 | 南韓商法姆拜歐韓國股份有限公司 | 結腸緩瀉錠劑及包含彼之結腸緩瀉劑 |
| WO2025259039A1 (ko) * | 2024-06-13 | 2025-12-18 | 주식회사태준제약 | 장정결을 위한 고형제제 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102111094B1 (ko) | 2018-06-18 | 2020-05-14 | 주식회사 한국팜비오 | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE277739T1 (de) * | 1996-10-28 | 2004-10-15 | Gen Mills Inc | Einbettung und einkapselung von teilchen zur kontrollierten abgabe |
| AUPR590701A0 (en) * | 2001-06-25 | 2001-07-19 | Colocaps Pty Ltd | Laxative preparation |
| WO2007099398A2 (en) * | 2005-09-27 | 2007-09-07 | Naturalite Benelux B.V. | Methods and compositions for treatment of skin |
| JP2008115085A (ja) * | 2006-11-01 | 2008-05-22 | Tendou Seiyaku Kk | 緩下剤 |
| US20130189377A1 (en) * | 2010-07-27 | 2013-07-25 | Norgine Bv | Compositions |
| BR112013014827A2 (pt) * | 2010-12-13 | 2016-10-04 | Antony Wettstein | formulações gástricas e colônicas e métodos para produzir e usar as mesmas |
| KR20140044628A (ko) * | 2012-10-05 | 2014-04-15 | 주식회사태준제약 | 신규한 폴리에틸렌글리콜과 비타민 씨를 함유하는 안정성이 개선된 장관 하제 조성물 |
| KR101423005B1 (ko) * | 2013-10-17 | 2014-07-28 | 강윤식 | 장 세정용 조성물 |
| KR101659746B1 (ko) * | 2014-01-28 | 2016-09-26 | 주식회사한국파마 | 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법 |
| KR20180091572A (ko) * | 2017-02-07 | 2018-08-16 | 주식회사 한국팜비오 | 경구투여용 대장하제조성물 |
| KR102127003B1 (ko) * | 2017-10-12 | 2020-06-25 | 주식회사 한국팜비오 | 황산염을 포함하는 대장 하제 조성물 |
| KR20190093490A (ko) * | 2018-02-01 | 2019-08-09 | 주식회사태준제약 | 장세척 조성물 |
-
2021
- 2021-12-30 KR KR1020210193139A patent/KR102669683B1/ko active Active
- 2021-12-30 JP JP2023539331A patent/JP2024501839A/ja active Pending
- 2021-12-30 CA CA3202758A patent/CA3202758A1/en active Pending
- 2021-12-30 US US18/270,476 patent/US20240075060A1/en active Pending
- 2021-12-30 EP EP21915886.2A patent/EP4272734A4/en active Pending
- 2021-12-30 WO PCT/KR2021/020327 patent/WO2022146089A1/ko not_active Ceased
-
2023
- 2023-03-17 KR KR1020230035478A patent/KR20230043086A/ko active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102111094B1 (ko) | 2018-06-18 | 2020-05-14 | 주식회사 한국팜비오 | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4272734A4 (en) | 2024-12-04 |
| EP4272734A1 (en) | 2023-11-08 |
| KR20220097340A (ko) | 2022-07-07 |
| US20240075060A1 (en) | 2024-03-07 |
| WO2022146089A1 (ko) | 2022-07-07 |
| CA3202758A1 (en) | 2022-07-07 |
| KR20230043086A (ko) | 2023-03-30 |
| JP2024501839A (ja) | 2024-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6723340B2 (en) | Optimal polymer mixtures for gastric retentive tablets | |
| KR101012533B1 (ko) | 프리가발린, 매트릭스 형성제 및 팽윤제를 함유하는 1일1회 투여를 위한 경구용 고체 제약 조성물 | |
| ES2584866T3 (es) | Composición purgante para el colon con agente aglutinante soluble | |
| US9492541B2 (en) | Phenylepherine containing dosage form | |
| CN106943355B (zh) | 药物组合物 | |
| US20040062800A1 (en) | Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles | |
| KR20230043086A (ko) | 장세척을 위한 경구용 고형제제 | |
| US20030158261A1 (en) | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles | |
| EP0749308B1 (en) | Film coated tablet of paracetamol and domperidone | |
| AU2010313571B2 (en) | Solid pharmaceutical compositions containing an integrase inhibitor | |
| AU2002249881A1 (en) | Sustained release pharmaceutical dosage forms with minimized PH dependent dissolution profiles | |
| CN100389751C (zh) | 含扑热息痛的吞咽片剂 | |
| JPH09504280A (ja) | センナ剤形 | |
| EP3013327B1 (en) | Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin | |
| JP2008285434A (ja) | 口腔内速崩壊錠 | |
| CZ20033340A3 (en) | Swallow tablet comprising paracetamol | |
| US7943585B2 (en) | Extended release antibiotic composition | |
| US20060159751A1 (en) | Controlled release pharmaceutical compositions of carbidopa and levodopa | |
| CN116801888A (zh) | 用于结肠清洁的口服固体制剂 | |
| AU2011379627A1 (en) | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof | |
| MX2010009917A (es) | Composicion de liberacion modificada que comprende doxofilina. | |
| EP1880722A1 (en) | Pharmaceutical compositions of ciprofloxacin | |
| KR20250176963A (ko) | 장정결을 위한 고형제제 | |
| KR102635438B1 (ko) | 장 세척을 위한 고형제제 및 이의 제조방법 | |
| US20150224056A1 (en) | Pharmaceutical compositions of ibuprofen and famotidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| A302 | Request for accelerated examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PA0302 | Request for accelerated examination |
St.27 status event code: A-1-2-D10-D17-exm-PA0302 St.27 status event code: A-1-2-D10-D16-exm-PA0302 |
|
| D13-X000 | Search requested |
St.27 status event code: A-1-2-D10-D13-srh-X000 |
|
| D14-X000 | Search report completed |
St.27 status event code: A-1-2-D10-D14-srh-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| AMND | Amendment | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PX0901 | Re-examination |
St.27 status event code: A-2-3-E10-E12-rex-PX0901 |
|
| PX0601 | Decision of rejection after re-examination |
St.27 status event code: N-2-6-B10-B17-rex-PX0601 |
|
| X601 | Decision of rejection after re-examination | ||
| PA0107 | Divisional application |
St.27 status event code: A-0-1-A10-A18-div-PA0107 St.27 status event code: A-0-1-A10-A16-div-PA0107 |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
St.27 status event code: A-3-3-V10-V11-apl-PJ0201 |
|
| E14-X000 | Pre-grant third party observation filed |
St.27 status event code: A-2-3-E10-E14-opp-X000 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2023101000782; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20230410 Effective date: 20240425 |
|
| PJ1301 | Trial decision |
St.27 status event code: A-3-3-V10-V15-crt-PJ1301 Decision date: 20240425 Appeal event data comment text: Appeal Kind Category : Appeal against decision to decline refusal, Appeal Ground Text : 2021 0193139 Appeal request date: 20230410 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023101000782 |
|
| PS0901 | Examination by remand of revocation |
St.27 status event code: A-6-3-E10-E12-rex-PS0901 |
|
| GRNO | Decision to grant (after opposition) | ||
| PS0701 | Decision of registration after remand of revocation |
St.27 status event code: A-3-4-F10-F13-rex-PS0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |